Distinctive role of Stat3 and Erk-1/2 activation in mediating interferon-γ inhibition of TGF-β1 action

American Journal of Physiology - Renal Physiology

Volumn 290, Issue 5, 2006, Pages

  Giannopoulou, Myrto ^a   Iszkula, Steven C ^a   Dai, Chunsun ^a   Tan, Xiaoyue ^a   Yang, Junwei ^b   Michalopoulos, George K ^a   Liu, Youhua ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Renal fibrosis; Signal transducer and activator of transcription 3; Transforming growth factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHA SMOOTH MUSCLE ACTIN; FIBRONECTIN; GAMMA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT CYTOKINE; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; DRUG INHIBITION; DRUG MECHANISM; HUMAN; HUMAN CELL; KIDNEY TUBULE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 33646583820     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00388.2005     Document Type: Article

References (36)

1. Baroni GS, D'Ambrosio L, Curto P, Casini A, Mancini R, Jezequel AM, and Benedetti A. Interferon γ decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 23: 1189-1199, 1996.
2. Bottinger EP and Bitzer M. TGF-β signaling in renal disease. J Am Soc Nephrol 13: 2600-2610, 2002.
3. 1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. J Am Soc Nephrol 15: 1402-1412, 2004.
4. 1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling. J Biol Chem 278: 12537-12545, 2003.
5. Duncan MR and Berman B. γ Interferon is the lymphokine and β interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 162: 516-527, 1985.
6. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 15: 290-301, 2000.
7. Guijarro C and Egido J. Transcription factor-κB (NF-κB) and renal disease. Kidney Int 59: 415-424, 2001.
8. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, and Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350, 2002.
9. Jenkins BJ, Grail D, Nheu T, Najdovska M, Wang B, Waring P, Inglese M, McLoughlin RM, Jones SA, Topley N, Baumann H, Judd LM, Giraud AS, Boussioutas A, Zhu HJ, and Ernst M. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling. Nat Med 11: 845-852, 2005.
10. Johnson RJ, Lombardi D, Eng E, Gordon K, Alpers CE, Pritzl P, Floege J, Young B, Pippin J, Couser WG, and Gabbiani G. Modulation of experimental mesangial proliferative nephritis by interferon-γ. Kidney Int 47: 62-69, 1995.
11. Kalluri R and Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784, 2003.
12. Li Y, Yang J, Dai C, Wu C, and Liu Y. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 112: 503-516, 2003.
13. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15: 1-12, 2004.
14. Liu Y. Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. Am J Physiol Renal Physiol 287: F7-F16, 2004.
15. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69: 213-217, 2006.
16. Long J, Wang G, Matsuura I, He D, and Liu F. Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3). Proc Natl Acad Sci USA 101: 99-104, 2004.
17. Massague J. How cells read TGF-β signals. Nat Rev Mol Cell Biol 1: 169-178, 2000.
18. Mensah-Brown EP, Obineche EN, Galadari S, Chandranath E, Shahin A, Ahmed I, Patel SM, and Adem A. Streptozotocin-induced diabetic nephropathy in rats: the role of inflammatory cytokines. Cytokine 31: 180-190, 2005.
19. Miyazaki T, Katagiri H, Kanegae Y, Takayanagi H, Sawada Y, Yamamoto A, Pando MP, Asano T, Verma IM, Oda H, Nakamura K, and Tanaka S. Reciprocal role of ERK and NF-κB pathways in survival and activation of osteoclasts. J Cell Biol 148: 333-342, 2000.
20. Oldroyd SD, Thomas GL, Gabbiani G, and El-Nahas AM. Interferon-γ inhibits experimental renal fibrosis. Kidney Int 56: 2116-2127, 1999.
21. Pilmore HL, Yan Y, Eris JM, Hennessy A, McCaughan GW, and Bishop GA. Time course of upregulation of fibrogenic growth factors and cellular infiltration in a rodent model of chronic renal allograft rejection. Transpl Immunol 10: 245-254, 2002.
22. Polisson RP, Gilkeson GS, Pyun EH, Pisetsky DS, Smith EA, and Simon LS. A multicenter trial of recombinant human interferon γ in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels. J Rheumatol 23: 654-658, 1996.
23. Rockey DC, Maher JJ, Jarnagin WR, Gabbiani G, and Friedman SL. Inhibition of rat hepatic lipocyte activation in culture by interferon-γ. Hepatology 16: 776-784, 1992.
24. 1 expression in pig serum-induced rat liver fibrosis in vivo. J Hepatol 28: 471-479, 1998.
25. Shen H, Zhang M, Minuk GY, and Gong Y. Different effects of rat interferon α, β, and γ on rat hepatic stellate cell proliferation and activation. BMC Cell Biol 3: 9, 2002.
26. Shi Y and Massague J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113: 685-700, 2003.
27. Strutz F, Heeg M, Kochsiek T, Siemers G, Zeisberg M, and Muller GA. Effects of pentoxifylline, pentifylline and γ-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts. Nephrol Dial Transplant 15: 1535-1546, 2000.
28. Strutz F and Muller GA. Interstitial pathomechanisms underlying progressive tubulointerstitial damage. Kidney Blood Press Res 22: 71-80, 1999.
29. Takahara T, Sugiyama K, Zhang LP, Ando O, Fujii M, Yata Y, Bo J, Xue F, Minemura M, and Watanabe A. Cotreatment with interferon-α and -γ reduces liver fibrosis in a rat model. Hepatol Res 28: 146-154, 2004.
30. 1 in prevention of renal inflammation: role of Smad7. J Am Soc Nephrol 16: 1371-1383, 2005.
31. Yang J, Dai C, and Liu Y. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction. Am J Pathol 163: 621-632, 2003.
32. Yang J, Dai C, and Liu Y. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J Am Soc Nephrol 16: 68-78, 2005.
33. Yang J and Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 13: 96-107, 2002.
34. Yang J and Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159: 1465-1475, 2001.
35. 1-induced epithelial-to- mesenchymal transition and reverses chronic renal injury. Nat Med 9: 964-968, 2003.
36. Ziesche R, Hofbauer E, Wittmann K, Petkov V, and Block LH. A preliminary study of long-term treatment with interferon γ-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 341: 1264-1269, 1999.